The largest database of trusted experimental protocols
> Disorders > Mental or Behavioral Dysfunction > Addictive Behavior

Addictive Behavior

Addictive Behavior refers to a range of compulsive actions or urges that can have detrimental effects on an individual's physical, mental, and social well-being.
This term encompasses a variety of addictions, including substance abuse, gambling, gaming, and other behavioral addictions.
Addictive behaviors are characterized by a loss of control, continued engagement despite negative consequences, and a strong craving or urge to engage in the behavior.
Understanding the underlying mechanisms and risk factors for addictive behaviors is crucial for developing effective prevention and treatment strategies.
Researchers and clinicians can leverage powerful AI-driven tools like PubCompare.ai to optimize their research on addictive behavior protocols, identifying the best practices and products from the literature, preprints, and patents.

Most cited protocols related to «Addictive Behavior»

Cases were classified using the Autism Diagnostic Interview-Revised (ADI-R) and Autism Diagnostic Observation Schedule (ADOS) instruments and those with known karyotypic abnormalities or genetic disorders were excluded. Informed consent was obtained from all families and procedures had approval from institutional review boards. DNA was obtained from blood or buccal-swabs (73% of cases; 75% of controls) or cell-lines (22% of cases; 25% of controls) (in 5% of cases the DNA source was not identified). The 1,287 EA controls passing all QC-filters included 1,261 individuals recruited as controls for the study of addiction (SAGE)15 (link) and 26 HapMap samples (from Illumina). An additional 3,677 EA controls from three separate studies genotyped on other platforms were also used. Raw data from ASD family (Accession pending) and SAGE control (Accession: phs000092.v1.p1) genotyping are at NCBI dbGAP. CNVs were analysed using PLINK v1.0730 (link), R stats and custom scripts. Primary analyses were robust to potential systematic measurement differences between cases and controls; it was not possible to control for site but we controlled for the overall extent and number of CNVs for all burden comparisons, and obtained a consistent enriched gene count in ASD cases compared to controls.
Publication 2010
Addictive Behavior Autistic Disorder BLOOD Cell Lines Cheek Diagnosis Ethics Committees, Research Genes, vif HapMap Hereditary Diseases
The Italian translation of the BSMAS (Andreassen, Billieux, et al., 2016 (link)) was used to assess the experiences in the use of social media over the past year. The BSMAS contains six items reflecting core addiction elements (i.e., salience, mood modification, tolerance, withdrawal, conflict, and relapse; Griffiths, 2005 ). Each item deals with experiences within a time frame of 12 months and is answered on a 5-point Likert scale ranging from 1 (very rarely) to 5 (very often). Sample items include: “How often during the last year have you used social media so much that it has had a negative impact on your job/studies?” and “How often during the last year have you felt an urge to use social media more and more?” (see Appendix).
Publication 2017
Addictive Behavior Feelings Immune Tolerance Mood Reading Frames Relapse
To assess problematic social media use, the Bergen Social Media Addiction Scale (BSMAS; [11 ]) was used. The 6-item scale was adapted from the previously validated Bergen Facebook Addiction Scale (BFAS; [10 (link)]). The original scale specifically assessed problematic Facebook use during the last year. The scale incorporated the theoretical framework of the addiction components of the biopsychosocial model [31 ]. The BFAS was developed by selecting the items with the highest possible factor loadings for each component (i.e., salience, mood modification, tolerance, withdrawal symptoms, conflict, and relapse) from an item-pool of 18 initial items. In the present study, the Bergen Social Media Addiction Scale (BSMAS) which is based on rephrasing of the BFAS, was to assess social media use in general over the past 12 months. The scale was translated to Hungarian and then back-translated by independent translators. The back-translation was then compared with the original scale and adjustments were made as necessary. The items are answered on a 5-point scale (“never” to “always”). The Cronbach’s alpha of the translated BSMAS was .85 in the present sample.
Full text: Click here
Publication 2017
Addictive Behavior Immune Tolerance Mood Relapse Social Media Addiction Withdrawal Symptoms
A mental health research reference group formed of approximately 50 individuals (see supplementary Appendix 1 available at https://doi.org/10.1192/bjo.2019.100) participated in discussions about a strategy for mental health phenotyping in UK Biobank, including a workshop in January 2015. From this, a smaller steering group was established and led the development of the MHQ. The group recommended that the MHQ should concentrate on depression, as it was likely to represent the greatest burden in the cohort, with some questions about other common disorders, including anxiety, alcohol misuse and addiction, plus risk factors for mental disorders not captured at participants' baseline assessment.
The intention was to create a composite questionnaire out of previously existing and validated measures, taking into account participant acceptability (time, ease of use and ensuring questions were unlikely to offend), scope for collaborations with international studies (for example the Psychiatric Genomics Consortium) through making results comparable, and the need to balance depth and breadth of phenotyping. The base of the questionnaire was the measurement of lifetime depressive disorder using the Composite International Diagnostic Interview Short Form (CIDI-SF),18 modified to provide lifetime history, as used to identify cases and controls for some existing studies in the Psychiatric Genomics Consortium.19 The CIDI-SF uses a branching structure with screening questions and skip rules to limit detailed questions to the relevant areas for each participant. Other measures were then added to this, as summarised in supplementary Table SM1. Where the group were unable to find existing measures that fulfilled these criteria, questions were written or adapted, as indicated in supplementary Table SM1. These sections have not been externally validated, but the questions along with the full questionnaire can be seen on the UK Biobank website (http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=22), for researchers to evaluate.
Full text: Click here
Publication 2020
Addictive Behavior Anxiety Diagnosis Disorder, Depressive Ethanol Mental Disorders Mental Health Vision

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2012
Addictive Behavior Conditioning, Classical Ethanol Gills Patients Pharmaceutical Preparations Relapse Retention (Psychology) Substance Use Tooth Attrition

Most recents protocols related to «Addictive Behavior»

The 3 month post-treatment follow-up telephone interview asked about the use of alcohol or drugs during the last four weeks. Patients indicated how often they had used alcohol/drugs during this period, with the following response options: “less than once a week,” “approximately weekly,” “2–4 times a week,” “daily or almost daily”. We defined relapse as return to regular use [15 (link)], thus those who reported using alcohol or drugs 2–4 times or more per week were categorized as having a relapse. The interview also enquired about any contact (yes/no) with outpatient SUD treatment services; and/or a community mental health and addiction health care provider; and/or readmission to SUD inpatient treatment. A small number of patients who reported readmission to SUD treatment was included in the relapse group (see also [34 (link)].
Full text: Click here
Publication 2023
Addictive Behavior Ethanol Health Personnel Health Services, Outpatient Hospitalization Mental Health Patients Pharmaceutical Preparations Relapse
The sample comprised 611 patients who were included in the prospective cohort study, of whom 289 patients (47.3%) had at least one co-occurring psychiatric diagnosis (F20-F99).
In total, 426 of the patients participated in the follow-up interview 3 months after discharge from treatment (70%), of whom 206 (48.4%) were patients with COD. The follow-up response rate was similar for patients with COD (71.3%) and those without COD (68.3%). Among patients with COD, those who did not respond were more likely younger (OR = 2.54, p = 0.002), with lower education level (OR = 1.77, p = 0.035), and less likely to have an alcohol use disorder (OR = 0.588, p = 0.053). Among patients without COD, those who were lost for follow-up appeared more likely younger (OR = 2.157, p = 0.002), and without a permanent housing situation (OR = 1.694, p = 0.042). About half of those who were reached at follow-up (n = 227) reported they had been in contact with SUD outpatient treatment services during the last month. Slightly fewer patients (n = 194) reported contact with a community health provider. The probability of contact with outpatient SUD services was somewhat higher for patients with COD (58.3%) than for patients without COD (48.6%) (p = 0.047). There was no difference between the groups regarding any contact with community mental health and addiction services.
Full text: Click here
Publication 2023
Addictive Behavior Alcohol Use Disorder Care, Ambulatory Diagnosis, Psychiatric Health Services, Outpatient Mental Health Patient Discharge Patients Youth
The present population based cross-sectional study, used the national database on people diagnosed with HIV from 1986 to 2016 (11 (link)). The data is managed by the Iranian Ministry of Health and Medical Education (MOHME) covering all 31 provinces. In Iran, MOHME integrated the HIV/AIDS program into a broad and coherent structure of the national health care system. The routine initial HIV diagnostic tests include ELISA and Western Blot. The confirmed HIV cases are reported to the regional health centers and then to the AIDS coordination department in MOHME. As the result, the national database takes several years to be completed as after collecting data from all provinces the data goes under huge mining and cleaning procedures to make it ready for any particular research use.
After being registered with the system, every HIV-positive individual is to receive standard treatments and gets routine medical follow-up at least twice a year in local HIV centers. All individuals' data is recorded in an unified online registration system under MOHME after being checked and cleaned by the local registry centers (11 (link)). For each HIV case, at the time of diagnosis, data on demographic characteristics and HIV associated behaviors is obtained via an interview conducted by trained and experienced health staffs in all counties. The collected information includes age, gender (female or male), level of education (elementary, high school, or above), marital status (married, single), occupation (employed or unemployed/housewife), year of HIV diagnosis, history of addiction (yes, no), and major HIV related behaviors. The predefined major behaviors, include history of drug injection (yes, no), out of marriage sexual contact (yes, no), and other conditions (i.e., mother to child transmission, blood transfusion, having sex with the same sex, occupational exposure, and no reported related behavior).
We used the annual number of new cases to define the trend of risky behaviors during the study period. As each individual could report more than one HIV related behavior, we used a logistic regression model for each of the risk factors separately to define their associated factors. To handle missing data, we used multiple imputation via applying Chained Equations (MICE) method before running multivariate logistic regression analysis. Analysis was conducted in SPSS, version 22 and STATA, version 14.0 (Stata Corporation, College Station, TX).
Full text: Click here
Publication 2023
Acquired Immunodeficiency Syndrome Addictive Behavior Blood Transfusion Diagnosis Diagnostic Tests, Routine Education, Medical Enzyme-Linked Immunosorbent Assay Males Maternal-Fetal Infection Transmission Occupational Exposure Pharmaceutical Preparations Western Blotting Woman
All study procedures were approved by the Institutional Review Board of Virginia Commonwealth University. CD and HC were recruited from Richmond, Virginia, via flyers, advertisements, and in-person recruitment at outpatient addiction treatment clinics (CD only). CD were excluded if they tested positive for any illicit drug other than cocaine or cannabis, but no restrictions regarding cocaine or cannabis use were imposed during recruitment. Written informed consent was obtained from all subjects. Subjects underwent screenings for medical, psychiatric, and substance use histories, and a physical examination. The Structured Clinical Interview for DSM-IV [(35 ); SCID-IV] was used to diagnose DSM-IV Cocaine Dependence (36 ). Inclusion criteria were DSM-IV diagnosed Cocaine Dependence (for CD) and age between 18 and 70 years. Exclusion criteria were history of schizophrenia, seizure disorder, major head trauma, any changes to psychoactive medications within the previous 30 days, or any other DSM-IV substance use disorder diagnosis. Additional HC exclusion criteria were any history of substance use disorder. Subject data was pooled from three separate studies – two studies in which delay discounting and MRI measures were obtained during a baseline period and one study in which the delay discounting and MRI measures were obtained two hours after administration of a placebo dose in a mirtazapine medication study (i.e., subjects had received either no mirtazapine dose or a single low mirtazapine dose 7 days prior to the measurement of delay discounting and MRI data used for this study). Participants were asked to refrain from tobacco use one hour before and caffeine consumption 3 hours before their MRI scan. Urine drug screens (UDS) and alcohol breath screens were obtained before their MRI scan on the day of the scan. 28 CD and 28 HC met the inclusion and exclusion criteria. Given that these two groups differed statistically in mean age and also in mean years of education attained, we performed a planned analysis after matching the two groups more closely for age and years of education. This more closely matched group analysis included 22 CD and 22 HC. We included an equal number of subjects in each group per the recommendations of the authors of the FSL software which we used for our functional connectivity analysis [(37 ), p. 67].
Full text: Click here
Publication 2023
Addictive Behavior Caffeine Cannabis Cocaine Cocaine Dependence Craniocerebral Trauma Diagnosis Epilepsy Ethanol Ethics Committees, Research Illicit Drugs Mirtazapine MRI Scans Physical Examination Placebos Psychotropic Drugs Radionuclide Imaging Schizophrenia SCID Mice Substance Abuse Detection Substance Use Substance Use Disorders Urine
Social anxiety was assessed with the French version (Douillez et al. 2008 ) of the Fear of Negative Evaluation (FNE; Watson and Friend 1969 (link)). The FNE consists of 30 items rated as 1 = “true” or 0 = “false” (e.g., “I am afraid others will not approve of me”). Scores range from 0 to 30 with higher scores indicating higher levels of social anxiety.
Paranoia was assessed with the French version (Della Libera et al. 2021 (link)) of the Green et al. Paranoid Thoughts Scale, part B (GPTS-B; Green et al. 2008 (link)). The GPTS-B consists of 16 items (e.g., “People have intended me harm”). Participants rate the intensity of such thoughts during the last month on a 5-point scale ranging from 1 = “not at all” to 5 = “totally”. Scores range from 16 to 80 with higher scores indicating a higher level of paranoia.
Severity of depressive symptoms experienced during the last 7 days were assessed with the French version (Fuhrer and Rouillon 1989 (link)) of the Center for Epidemiologic Studies—Depression (CES-D; Radloff 1977 (link)). The CES-D consists of 20 items rated on a scale ranging from 0 = “never” to 3 = “frequently, all the time”. Scores range from 0 to 60 with higher scores indicating higher symptom severity. In addition, a score of 16 or above indicates the presence of depressive symptomatology.
Alcohol consumption was assessed with the French version (Gache et al. 2005 (link)) of the Alcohol Use Disorder Identification Test (AUDIT; Saunders et al. 1993 (link)). The AUDIT includes 10 multiple-choice items measuring alcohol consumption, alcohol dependence and alcohol-related problems. A score ranging from 0 to 40 is obtained by adding the score of each item. A score above 10 indicates an at-risk consumption (Fleming et al. 1991 (link)).
Nicotine consumption was assessed with a series of questions where participants indicated whether they were smokers, former smokers or non-smokers. The average number of cigarettes smoked par day, the frequency and duration of their addiction were asked for smokers and former smokers. Former smokers were also asked to indicate when they stopped smoking, the number of years they smoked, and the average number of cigarettes they smoked each day. These questions allowed to identify the smoking pattern of the current and former smokers.
Publication 2023
Addictive Behavior Alanine Transaminase Alcoholic Intoxication, Chronic Alcohol Problem Alcohol Use Disorder Depressive Symptoms Fear Friend Nicotine Non-Smokers Paranoia Social Anxiety Thinking

Top products related to «Addictive Behavior»

Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United States, Austria, Japan, Belgium, United Kingdom, Cameroon, China, Denmark, Canada, Israel, New Caledonia, Germany, Poland, India, France, Ireland, Australia
SAS 9.4 is an integrated software suite for advanced analytics, data management, and business intelligence. It provides a comprehensive platform for data analysis, modeling, and reporting. SAS 9.4 offers a wide range of capabilities, including data manipulation, statistical analysis, predictive modeling, and visual data exploration.
Sourced in United States, United Kingdom, Japan, Germany, Austria, Belgium, France, Denmark
SPSS 24.0 is a statistical software package developed by IBM. It provides data management, analysis, and reporting capabilities. The software is designed to handle a wide range of data types and is commonly used for social science research, market research, and business analytics.
Sourced in United States, United Kingdom, Japan, Austria, Germany, Denmark, Czechia, Belgium, Sweden, New Zealand, Spain
SPSS version 25 is a statistical software package developed by IBM. It is designed to analyze and manage data, providing users with a wide range of statistical analysis tools and techniques. The software is widely used in various fields, including academia, research, and business, for data processing, analysis, and reporting purposes.
Sourced in United States
The GoldenGate platform is a high-throughput genotyping system designed for the analysis of single nucleotide polymorphisms (SNPs) and other genetic variations. The platform combines array-based technology with a robust assay to deliver accurate and efficient genotyping results.
Sourced in United States, United Kingdom, Japan, Austria, Germany, Belgium, Israel, Hong Kong, India
SPSS version 23 is a statistical software package developed by IBM. It provides tools for data analysis, data management, and data visualization. The core function of SPSS is to assist users in analyzing and interpreting data through various statistical techniques.
The Addiction Biology SNP Array is a lab equipment product designed for genetic analysis. It is a high-throughput genotyping platform that allows researchers to assess genetic variants associated with addiction-related traits and behaviors.
Sourced in United States, Canada, France, Italy, Japan, United Kingdom
Long-Evans rats are a commonly used rodent model in research. They are a outbred strain of rat that originated from the Long-Evans University. Long-Evans rats are known for their characteristic hooded coat coloration.

More about "Addictive Behavior"

Addictive Behavior, also known as Compulsive Behavior or Behavioral Addiction, refers to a range of uncontrollable actions, urges, or dependencies that can have detrimental effects on an individual's physical, mental, and social well-being.
This term encompasses various addictions, including substance abuse (e.g., drug, alcohol, nicotine), gambling, gaming, and other behavioral addictions.
Addictive behaviors are characterized by a loss of control, persistent engagement despite negative consequences, and a strong craving or urge to participate in the behavior.
Understanding the underlying mechanisms and risk factors for these addictive behaviors is crucial for developing effective prevention and treatment strategies.
Researchers and clinicians can leverage powerful AI-driven tools like PubCompare.ai to optimize their research on addictive behavior protocols.
These tools can help identify the best practices and products from the literature, preprints, and patents, allowing for more informed decision-making and improved outcomes.
In the field of addiction research, various statistical analysis software, such as SAS version 9.4, SPSS 24.0, and SPSS version 25, are commonly used to analyze data and evaluate the effectiveness of interventions.
Additionally, emerging technologies like the GoldenGate platform and genetic analysis tools, such as the Addiction biology SNP array, have been utilized to uncover the biological underpinnings of addictive behaviors.
Studying animal models, such as Long-Evans rats, has also provided valuable insights into the neurobiological and behavioral mechanisms underlying addictive disorders.
By leveraging these tools and resources, researchers and clinicians can work towards a better understanding and more effective treatment of addictive behaviors.